Oxycodone is not considered safe during pregnancy, particularly with regular or prolonged use. While short-term use under medical supervision hasn’t been conclusively linked to birth defects, it carries real risks to the baby, especially in the third trimester. The most significant concern is neonatal abstinence syndrome, a withdrawal condition that can affect newborns exposed to opioids before birth.
Birth Defect Risk in the First Trimester
One of the first questions many people have is whether taking oxycodone early in pregnancy could cause structural problems in the baby. The available evidence is somewhat reassuring on this specific point. A retrospective study examining first-trimester oxycodone exposure found no statistically significant increase in congenital anomalies, though the data did show a trend worth noting (an odds ratio of 1.74, meaning a possible but not confirmed increase). Overall, prenatal oxycodone exposure was not associated with a higher rate of birth defects.
That said, the absence of a clear link to malformations doesn’t make the drug safe. The risks shift depending on when during pregnancy you take it, how much, and for how long.
Third Trimester Use and Newborn Withdrawal
The most well-documented risk of oxycodone in pregnancy is neonatal abstinence syndrome (NAS). This is essentially withdrawal: when a baby has been exposed to opioids in the womb, their body can become physically dependent. After birth, when that supply stops, the baby goes through withdrawal symptoms that can include tremors, excessive crying, poor feeding, vomiting, diarrhea, and in some cases seizures.
NAS symptoms typically appear within 24 to 48 hours of birth, though they can show up as late as one week after delivery. In some cases, withdrawal symptoms continue for up to four weeks. The likelihood and severity of NAS depend on several factors: how long the mother used opioids during pregnancy, the dose, whether other medications were also taken, whether the baby was born preterm, and the baby’s size at birth. Third-trimester use carries the highest risk because the baby’s exposure is most recent and sustained heading into delivery.
Babies born with NAS are typically monitored in the hospital for several days after birth. Mild cases may only need comfort measures like swaddling, skin-to-skin contact, and a quiet environment. More severe cases can require medication to ease the baby through withdrawal safely, sometimes extending the hospital stay to weeks.
Preterm Birth and Growth Concerns
Frequent opioid use during pregnancy has been linked to several complications beyond NAS. These include poor fetal growth, low amniotic fluid levels, stillbirth, preterm delivery, and higher rates of cesarean section. These outcomes are more commonly reported in people using opioids at higher doses or for longer durations than prescribed.
One study from a First Nations population in Ontario found that preterm birth rates were notably higher among babies exposed to oxycodone in utero: 8.2% compared to 2.3% in unexposed newborns. However, the broader research on birth weight and preterm birth remains inconclusive, with several studies finding no association between oxycodone use and low birth weight. The picture is mixed enough that the risk can’t be dismissed, but it also hasn’t been firmly established at typical prescribed doses.
Dose and Duration Matter
There’s no established “safe” dose of oxycodone during pregnancy. What the research consistently shows is that risk scales with exposure. Higher doses and longer durations of use increase the chance of complications, particularly NAS. A single short course for acute pain (such as after a procedure) poses a different level of risk than daily use over weeks or months.
The MotherToBaby fact sheet from the National Institutes of Health notes that the worst outcomes are more commonly reported in people taking opioid medication “in greater amounts or for longer than recommended.” This means that if oxycodone is genuinely necessary, using the lowest effective dose for the shortest possible time is the guiding principle.
Breastfeeding After Oxycodone Use
Oxycodone does pass into breast milk. Studies estimate that an exclusively breastfed infant receives roughly 2.8% to 8% of the mother’s weight-adjusted dose through nursing. That may sound small, but newborns process drugs far more slowly than adults, and the effects can accumulate.
In one study, mothers taking oxycodone reported signs of sedation in 20% of their breastfed infants, compared to just 0.5% among mothers taking only acetaminophen. Signs of concern in a nursing infant include unusual sleepiness, difficulty breastfeeding, shallow or irregular breathing, and limpness. There are documented cases of serious infant sedation requiring emergency care, including one case where a 4-day-old developed lethargy, pinpoint pupils, hypothermia, and a poor sucking reflex linked to oxycodone in breast milk.
If you’re taking oxycodone while breastfeeding, the goal is the lowest dose for the shortest time, with close monitoring of your baby’s behavior and breathing patterns.
Safer Alternatives for Pain in Pregnancy
For most types of pain during pregnancy, there are options that carry far less risk. Acetaminophen is the recommended first-line medication for pain that requires drug treatment. It provides comparable relief to anti-inflammatory drugs without affecting blood clotting or prostaglandin levels, both of which matter during pregnancy.
Non-drug approaches have strong evidence behind them, particularly for the back and pelvic pain that’s common in pregnancy. Physical therapy, including pelvic tilts, stretching, and strengthening exercises, has been shown to reduce lumbar pain effectively. Acupuncture is generally considered safe during pregnancy and works by activating the body’s natural pain-relief pathways, though practitioners should avoid points that can stimulate the cervix and uterus. Water therapy has been shown to reduce both pain levels and the need for sick leave in pregnant women with back pain. Manual therapy, cognitive behavioral therapy, and biofeedback are also considered safe throughout all trimesters.
For chronic pain conditions, the American College of Obstetricians and Gynecologists recommends a multimodal approach that prioritizes nonpharmacological strategies (exercise, physical therapy, behavioral techniques) and nonopioid medications before considering opioids. The goal is to avoid or minimize opioid use for pain management during pregnancy whenever possible.
If You’re Already Taking Oxycodone
If you’re currently taking oxycodone and discover you’re pregnant, or if you’ve been using it regularly during pregnancy, do not stop abruptly. Sudden opioid withdrawal during pregnancy is associated with serious risks including preterm labor and fetal distress. For people with opioid use disorder, ACOG recommends opioid agonist therapy (a supervised medication program) rather than medically supervised withdrawal, because withdrawal leads to high relapse rates and worse outcomes for both mother and baby.
The key takeaway is that while oxycodone hasn’t been shown to cause birth defects, it is not a benign drug during pregnancy. The risks are real, dose-dependent, and concentrated in the third trimester. For most pain situations, safer alternatives exist and should be tried first.